Cargando…
The use of anti-TNFα medications for rheumatologic disease in pregnancy
Anti-TNFα medications have led to vast improvements in the treatment of inflammatory conditions, including rheumatoid arthritis and Crohn’s disease. As these diseases often afflict women in their reproductive years, the safety of these drugs during pregnancy is an important issue. Prospectively coll...
Autor principal: | Clowse, Megan EB |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971732/ https://www.ncbi.nlm.nih.gov/pubmed/21072312 |
Ejemplares similares
-
TNF-α/anti-TNF-α drugs and its effect on pregnancy outcomes
por: Dai, Fang-fang, et al.
Publicado: (2022) -
The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
por: Romanowska-Próchnicka, Katarzyna, et al.
Publicado: (2021) -
Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
por: Verstappen, Suzanne M M, et al.
Publicado: (2011) -
Managing pregnancy in inflammatory rheumatological diseases
por: Jain, Varsha, et al.
Publicado: (2011) -
Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic
por: Sadun, Rebecca E, et al.
Publicado: (2018)